vimarsana.com
Home
Live Updates
Axogen Reports Preliminary Unaudited Revenue for Fourth Quar
Axogen Reports Preliminary Unaudited Revenue for Fourth Quar
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 -- Axogen, Inc. , a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary...
Related Keywords
United States ,
Canada ,
South Korea ,
Russia ,
Germany ,
United Kingdom ,
Ukraine ,
Spain ,
Karen Zaderej ,
Haroldd Tamayo ,
Axogen Inc ,
Nasdaq ,
Unaudited Fourth Quarter ,
Year End Performance ,
Core Accounts ,
Nerve Graft ,
Soft Tissue ,
Avive Soft Tissue ,
Axoguard Nerve ,
Nerve Protector ,
Private Securities Litigation Reform Act ,
Middle East ,
Annual Report ,
Quarterly Report ,